Drugs Companies in Malaysia

The Malaysian government has been encouraging the development of the country’s pharmaceutical industry, with the goal of making Malaysia a regional hub for the production and distribution of drugs and pharmaceuticals. As a result, a number of multinational drug companies have set up operations in Malaysia, attracted by the country’s skilled workforce, developed infrastructure, and favorable tax regime.

The Malaysian pharmaceutical market is worth an estimated US$2.4 billion, and is expected to grow at a compound annual rate of 9.6% between 2015 and 2020. The government’s target is to increase the value of the pharmaceutical industry to RM30 billion (US$7.2 billion) by 2025.

The majority of drugs consumed in Malaysia are imported, with local production accounting for just 20% of the total market. However, the government is aiming to increase the share of locally-produced drugs to 30% by 2020. A number of initiatives have been launched to support this goal, including the establishment of a dedicated fund to support research and development in the pharmaceutical sector.

A number of multinational drug companies have set up operations in Malaysia, including Pfizer, GlaxoSmithKline, and AstraZeneca. These companies are attracted by the country